Sirio Pharma Co., Ltd. (300791.SZ)
CNY 25.0
(2.38%)
CNY 25.0
(2.38%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 481.05 Million CNY | 106.84% |
| 2022 | 232.57 Million CNY | -2.94% |
| 2021 | 239.61 Million CNY | -10.18% |
| 2020 | 266.76 Million CNY | 30.57% |
| 2019 | 204.31 Million CNY | -10.37% |
| 2018 | 227.94 Million CNY | 18.2% |
| 2017 | 192.83 Million CNY | 23.23% |
| 2016 | 156.49 Million CNY | 33.87% |
| 2015 | 116.89 Million CNY | 6.88% |
| 2014 | 109.36 Million CNY | -17.5% |
| 2013 | 132.57 Million CNY | 16.93% |
| 2012 | 113.38 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 545.49 Million CNY | 9.0% |
| 2024 Q3 | 539.06 Million CNY | -1.18% |
| 2024 Q1 | 500.43 Million CNY | 4.03% |
| 2023 FY | 481.05 Million CNY | 106.84% |
| 2023 Q4 | 481.05 Million CNY | 16.0% |
| 2023 Q3 | 414.71 Million CNY | -5.02% |
| 2023 Q2 | 436.61 Million CNY | -0.62% |
| 2023 Q1 | 439.34 Million CNY | 88.9% |
| 2022 FY | 232.57 Million CNY | -2.94% |
| 2022 Q4 | 232.57 Million CNY | -21.83% |
| 2022 Q3 | 297.54 Million CNY | -6.87% |
| 2022 Q2 | 319.49 Million CNY | 6.54% |
| 2022 Q1 | 299.89 Million CNY | 25.16% |
| 2021 Q4 | 239.61 Million CNY | -26.45% |
| 2021 Q2 | 324.86 Million CNY | -6.56% |
| 2021 FY | 239.61 Million CNY | -10.18% |
| 2021 Q1 | 347.67 Million CNY | 30.33% |
| 2021 Q3 | 325.8 Million CNY | 0.29% |
| 2020 Q2 | 256.33 Million CNY | -2.84% |
| 2020 Q3 | 274.64 Million CNY | 7.15% |
| 2020 Q1 | 263.83 Million CNY | 29.14% |
| 2020 Q4 | 266.76 Million CNY | -2.87% |
| 2020 FY | 266.76 Million CNY | 30.57% |
| 2019 Q3 | 210.57 Million CNY | -3.11% |
| 2019 FY | 204.31 Million CNY | -10.37% |
| 2019 Q4 | 204.31 Million CNY | -2.98% |
| 2019 Q2 | 217.33 Million CNY | 0.0% |
| 2019 Q1 | - CNY | -100.0% |
| 2018 FY | 227.94 Million CNY | 18.2% |
| 2018 Q2 | 209.6 Million CNY | 0.0% |
| 2018 Q4 | 227.94 Million CNY | 0.0% |
| 2017 FY | 192.83 Million CNY | 23.23% |
| 2016 FY | 156.49 Million CNY | 33.87% |
| 2015 Q3 | 121.84 Million CNY | 0.0% |
| 2015 Q4 | 116.89 Million CNY | -4.06% |
| 2015 FY | 116.89 Million CNY | 6.88% |
| 2014 FY | 109.36 Million CNY | -17.5% |
| 2013 FY | 132.57 Million CNY | 16.93% |
| 2012 FY | 113.38 Million CNY | 0.0% |